Rare primary central nervous system tumors

11Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An estimated 69,720 new cases of primary central nervous system tumors are expected to be diagnosed in 2013 based on projection using the 2013 Central Brain Tumor Registry of the United States (CBTRUS) Statistical Report (www.cbtrus.org). Meningiomas, gliomas, nerve sheath tumors, and pituitary tumors together constitute more than 85% of all primary central nervous system tumors diagnosed in the US. There are some tumors which constitute less than 1% of all brain tumors. The purpose of this paper is to provide an overview of the clinical, pathologic and therapeutic aspects of some of the more commonly encountered rare primary brain tumors, including atypical teratoid/rhabdoid tumor, choroid plexus carcinoma, ganglioglioma, hemangiopericytoma, and pleomorphic xanthoastrocytoma. & copy; C.D. Kubicky et al., 2014.

Cite

CITATION STYLE

APA

Kubicky, C. D., Sahgal, A., Chang, E. L., & Lo, S. S. (2014). Rare primary central nervous system tumors. Rare Tumors, 6(3), 105–110. https://doi.org/10.4081/rt.2014.5449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free